Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
(NASDAQ: ALLR) Delayed: 1.21 +0.05 (4.31%)
Previous Close $1.16    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.22    P/E N/A 
Day Low $1.11    EPS $ 
Volume 186,439